Thank you for your interest in applying to become a Discseel^® providing physician.

The Discseel^® Procedure provides high safety and efficacy for treating lumbar and cervical disc pathology when compared to other surgical and non-surgical treatments and is being performed more frequently by spine surgeons in the United States, Europe, and Asia. 

This procedure works by utilizing FDA approved Fibrin made by Baxter Pharmaceutical to first seal annular tears, then stimulate disc tissue growth, permanently repairing disc pathology.  A randomized, controlled study confirms the ability of Baxter’s Fibrin to regrow disc tissue and was awarded the NASS Outstanding Paper. Safety and efficacy profiles of the Discseel^® Procedure surpass all spine surgery study results.

If you believe you have the expertise to join our growing team of Discseel^® providers, please fill out the form below and we will reach out to you if we feel you are the right fit.